Cyclopentolate and Phenylephrine and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Cyclopentolate and Phenylephrine and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate / phenylephrine ophthalmic
Brand name: Cyclomydril
Synonyms: Cyclopentolate and phenylephrine ophthalmic
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate and Phenylephrine-Insulin degludec
- Cyclopentolate and Phenylephrine-Insulin Degludec (U-100) Prefilled Pens
- Cyclopentolate and Phenylephrine-Insulin Degludec (U-100) Vials
- Cyclopentolate and Phenylephrine-Insulin Degludec (U-200) Prefilled Pens
- Cyclopentolate and Phenylephrine-Insulin degludec and liraglutide
- Cyclopentolate and Phenylephrine-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Cyclopentolate and phenylephrine ophthalmic
- Insulin aspart, recombinant Subcutaneous-Cyclopentolate Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Cyclopentolate ophthalmic
- Insulin aspart, recombinant Subcutaneous-Cyclophosphamide
- Insulin aspart, recombinant Subcutaneous-Cyclophosphamide Capsules
- Insulin aspart, recombinant Subcutaneous-Cyclophosphamide Injection